Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Grabowski

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
BMC Neuroscience|August 5, 2008
Temporal gene expression profiling reveals CEBPD as a candidate regulator of brain disease in prosaposin deficient miceYing Sun, Li Jia, Michael T Williams, et al.
Molecular Genetics and Metabolism|January 2, 2017
Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher RegistryAmal El-Beshlawy, Anna Tylki-Szymanska, Ashok Vellodi, et al.
Plos One|May 3, 2011
Isofagomine in vivo effects in a neuronopathic Gaucher disease mouseYing Sun, Huimin Ran, Benjamin Liou, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects, <i>GBA1</i> mutation-associated pathologies and diseasesXiangli Zhao, Yi Lin, Benjamin Liou, et al.
SLAS Discovery : Advancing Life Sciences R & D|July 18, 2017
Tissue Localization of Glycosphingolipid Accumulation in a Gaucher Disease Mouse Brain by LC-ESI-MS/MS and High-Resolution MALDI Imaging Mass SpectrometryE Ellen Jones, Wujuan Zhang, Xueheng Zhao, et al.
Ebiomedicine|February 4, 2018
Chitinase-3-like Protein 1: A Progranulin Downstream Molecule and Potential Biomarker for Gaucher DiseaseJinlong Jian, Yuehong Chen, Rossella Liberti, et al.
European Journal of Pediatrics|December 17, 2003
Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statementsGregory A Grabowski, Generoso Andria, Antonio Baldellou, et al.
European Journal of Pediatrics|December 17, 2003
Paediatric non-neuronopathic Gaucher disease: recommendations for treatment and monitoringAntonio Baldellou, Generoso Andria, Pauline E Campbell, et al.
Human Molecular Genetics|August 5, 2024
Intrinsic link between PGRN and Gba1 D409V mutation dosage in potentiating Gaucher diseaseYi Lin, Xiangli Zhao, Benjamin Liou, et al.
Human Molecular Genetics|December 18, 2009
Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouseYing Sun, Huimin Ran, Matt Zamzow, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
BMC Neuroscience|August 5, 2008
Temporal gene expression profiling reveals CEBPD as a candidate regulator of brain disease in prosaposin deficient miceYing Sun, Li Jia, Michael T Williams, et al.
Molecular Genetics and Metabolism|January 2, 2017
Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher RegistryAmal El-Beshlawy, Anna Tylki-Szymanska, Ashok Vellodi, et al.
Plos One|May 3, 2011
Isofagomine in vivo effects in a neuronopathic Gaucher disease mouseYing Sun, Huimin Ran, Benjamin Liou, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects, <i>GBA1</i> mutation-associated pathologies and diseasesXiangli Zhao, Yi Lin, Benjamin Liou, et al.
SLAS Discovery : Advancing Life Sciences R & D|July 18, 2017
Tissue Localization of Glycosphingolipid Accumulation in a Gaucher Disease Mouse Brain by LC-ESI-MS/MS and High-Resolution MALDI Imaging Mass SpectrometryE Ellen Jones, Wujuan Zhang, Xueheng Zhao, et al.
Ebiomedicine|February 4, 2018
Chitinase-3-like Protein 1: A Progranulin Downstream Molecule and Potential Biomarker for Gaucher DiseaseJinlong Jian, Yuehong Chen, Rossella Liberti, et al.
European Journal of Pediatrics|December 17, 2003
Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statementsGregory A Grabowski, Generoso Andria, Antonio Baldellou, et al.
European Journal of Pediatrics|December 17, 2003
Paediatric non-neuronopathic Gaucher disease: recommendations for treatment and monitoringAntonio Baldellou, Generoso Andria, Pauline E Campbell, et al.
Human Molecular Genetics|August 5, 2024
Intrinsic link between PGRN and Gba1 D409V mutation dosage in potentiating Gaucher diseaseYi Lin, Xiangli Zhao, Benjamin Liou, et al.
Human Molecular Genetics|December 18, 2009
Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouseYing Sun, Huimin Ran, Matt Zamzow, et al.
Pageof 13